BioMed Central Ltd Company Profile

21:38 EDT 20th March 2018 | BioPortfolio

BioMed Central is an independent publishing house committed to providing immediate open access to peer-reviewed biomedical research
All original research articles published by BioMed Central are made freely and permanently accessible online immediately upon publication. BioMed Central views open access to research as essential in order to ensure the rapid and efficient communication of research findings


Science Navigation Group Middlesex House
34-42 Cleveland Street
United KIngdom


Phone: 44 (0)20 7323 0323
Fax: 44 (0)20 7631 9926

News Articles [134 Associated News Articles listed on BioPortfolio]

BioMed X and Roche announce research collaboration in the field of immunology

BioMed X announced the initiation of a new research collaboration with F. Hoffmann-La Roche Ltd in the field of immunology. Within the framework of the agreement, BioMed X will launch a global call fo...

BioMed X and Boehringer Ingelheim start new joint research group

BioMed X announced today the start of a new joint research group with Boehringer Ingelheim at the BioMed X Innovation Center in Heidelberg. The focus of the group will be to identify novel regulatory ...

Q Biomed seeks FDA nod for new cancer bone pain drug facility

A regulatory filing was submitted to the FDA by Q BioMed for the approval of a new manufacturing facility that will produce S -More- 

Q BioMed, Washington Univ. team up in glaucoma

Washington University licensed Q BioMed Inc. an exclusive option to evaluate the growth differentiation factor 15 (GDF15) gene biomarker as a companion diagnostic with the MAN01 small molecule for gla...

THC BioMed Announces LOI to Acquire Farm and Greenhouses in Southern Ontario for Potential Cannabis Production - Video Available on

Vancouver, British Columbia--(Newsfile Corp. - February 16, 2018) - THC BioMed (CSE: THC) (OTCQB: THCBF) (FSE: TFHC), Canada's largest supplier of legal Cannabis Genetics, has entered into a Letter...

Q BioMed nets $5mm via FOPO

Specialty pharmaco Q BioMed Inc. netted $5mm through a follow-on public offering of 1.7mm common shares at $3.20. The company also issued 1.7mm five-year warrants to buy one share at an exercise price...

BeiGene to Generate New mAbs Using Harbour BioMed's Mouse Platform

Beijing's BeiGene licensed multi-year rights to use Harbour BioMed's H2L2 transgenic mouse platform, which generates fully human therapeutic monoclonal antibodies. Harbour BioMed, a Shanghai company, ...

THC BioMed's Subsidiary THC2GO Dispensers Submits Application to Operate Cannabis Retail Stores in Manitoba - Video Available on

Vancouver, British Columbia--(Newsfile Corp. - December 21, 2017) - THC BioMed's (CSE: THC) (OTCQB: THCBF) (FSE: TFHD) subsidiary, THC2GO Dispensers, has officially submitted its application to ope...

PubMed Articles [702 Associated PubMed Articles listed on BioPortfolio]

The Role of Publishers in Prevention of Misconducts in Medical Research: Springer and BioMed Central, Victim or Culprit.

Central serous chorioretinopathy following the use of phosphodiesterase 5 inhibitors.

Central serous chorioretinopathy occurs primarily in young caucasian men. It is characterized by the development of a serous detachment of the sensory retina with the apparition of a relative central ...

Corrigendum to "double sword role of EZH2 in leukemia" Biomed. Pharmacother. 98 (2018) 626-635.

Erratum to "Automatic Segmentation of Ultrasound Tomography Image".

[This corrects the article DOI: 10.1155/2017/2059036.].

Evaluation of the reduction in central and peripheral arterial blood pressure following an oral glucose load.

The clinical significance of measuring central arterial blood pressure has been recently discussed. Although the postprandial reduction in blood pressure is well known, postprandial changes in central...

Clinical Trials [1654 Associated Clinical Trials listed on BioPortfolio]

Amendment of rTSST-1 Variant Vaccine Phase 1 First-in-man Trail

Toxic Shock Syndrome (TSS) a severe condition with high morbidity and mortality results from the hosts overwhelming inflammatory response and cytokine storm. Staphylococcal superantigen to...

Reproducibility of Malaria Challenge in Healthy Volunteers

This is a prospective, single arm, single intervention safety and immunogenicity study in 6 healthy, malaria-naive adults, conducted to demonstrate the successful implementation of the wel...

Direct Measurement of Ideal Depth of Central Line

Total of 89 patients undergoing elective cardiac surgery will be enrolled. Right CVC insertion begins at their intersection of the cricoid cartilage level and the triangular point where t...

Temperature Control in Central Fever in the Neuro-ICU

There are few treatments for central fever (fever that is due to the central nervous system, as opposed to an infectious source). We hypothesize that an externally applied cooling blanket ...

Effect of the Bevel Direction of Puncture Needle on Success Rate and Complications During Central Venous Catheterization

To test the hypothesis that approaching the internal jugular vein with the needle bevel down would produce less injury to the vessel wall compared to the bevel up approach during central v...

Companies [628 Associated Companies listed on BioPortfolio]

BioMed Central Ltd

BioMed Central is an independent publishing house committed to providing immediate open access to peer-reviewed biomedical researchAll original research articles published by BioMed Central are made f...

Environmental Health journal

Environmental Health is an open access, peer-reviewed, online journal published by BioMed Central that considers manuscripts on all aspects of environmental and occupational medicine, and related stud...

Biomed Pharmaceuticals

The Company is a leading pharmacy provider of intravenous and injectable medications for patients with chronic disorders. Biomed treats a variety of immune deficient and autoimmun...

ILSI Biomed Israel 2011

The ILSI Biomed Israel 2011 is the central annual event of Israel's life science industry. It consists of an international professional conference, targeted at the best experts an...


Biomed AG wurde 1951 in Zürich gegründet und hat sich seither als Handelsunternehmen für pharmazeutische Produkte im Schweizer Markt etabliert. Biomed ist spezialisiert auf den Handel mit rezeptpfl...

More Information about "BioMed Central Ltd" on BioPortfolio

We have published hundreds of BioMed Central Ltd news stories on BioPortfolio along with dozens of BioMed Central Ltd Clinical Trials and PubMed Articles about BioMed Central Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioMed Central Ltd Companies in our database. You can also find out about relevant BioMed Central Ltd Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record